These Drug Companies Are Going Nuclear to Fight Cancer
Big pharma’s investments in nuclear medicine highlight how cancer treatment is shifting to targeted approaches.
Big pharma’s investments in nuclear medicine highlight how cancer treatment is shifting to targeted approaches.